Literature DB >> 23145215

Truncated Nucleosides as A(3) Adenosine Receptor Ligands: Combined 2-Arylethynyl and Bicyclohexane Substitutions.

Dilip K Tosh1, Silvia Paoletta, Khai Phan, Zhan-Guo Gao, Kenneth A Jacobson.   

Abstract

C2-Arylethynyladenosine-5'-N-methyluronamides containing a bicyclo[3.1.0]hexane ((N)-methanocarba) ring are selective A(3) adenosine receptor (AR) agonists. Similar 4'-truncated C2-arylethynyl-(N)-methanocarba nucleosides containing alkyl or alkylaryl groups at the N(6) position were low-efficacy agonists or antagonists of the human A(3)AR with high selectivity. Higher hA(3)AR affinity was associated with N(6)-methyl and ethyl (K(i) 3-6 nM), than with N(6)-arylalkyl groups. However, combined C2-phenylethynyl and N(6)-2-phenylethyl substitutions in selective antagonist 15 provided a K(i) of 20 nM. Differences between 4'-truncated and nontruncated analogues of extended C2-p-biphenylethynyl substitution suggested a ligand reorientation in AR binding, dominated by bulky N(6) groups in analogues lacking a stabilizing 5'-uronamide moiety. Thus, 4'-truncation of C2-arylethynyl-(N)-methanocarba adenosine derivatives is compatible with general preservation of A(3)AR selectivity, especially with small N(6) groups, but reduced efficacy in A(3)AR-induced inhibition of adenylate cyclase.

Entities:  

Year:  2012        PMID: 23145215      PMCID: PMC3491360          DOI: 10.1021/ml300107e

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  29 in total

1.  Structure-activity relationships of truncated C2- or C8-substituted adenosine derivatives as dual acting A₂A and A₃ adenosine receptor ligands.

Authors:  Xiyan Hou; Mahesh S Majik; Kyunglim Kim; Yuna Pyee; Yoonji Lee; Varughese Alexander; Hwa-Jin Chung; Hyuk Woo Lee; Girish Chandra; Jin Hee Lee; Seul-Gi Park; Won Jun Choi; Hea Ok Kim; Khai Phan; Zhan-Guo Gao; Kenneth A Jacobson; Sun Choi; Sang Kook Lee; Lak Shin Jeong
Journal:  J Med Chem       Date:  2011-12-28       Impact factor: 7.446

2.  Functionalized congeners of A3 adenosine receptor-selective nucleosides containing a bicyclo[3.1.0]hexane ring system.

Authors:  Dilip K Tosh; Moshe Chinn; Andrei A Ivanov; Athena M Klutz; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2009-12-10       Impact factor: 7.446

Review 3.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.

Authors:  Bertil B Fredholm; Adriaan P IJzerman; Kenneth A Jacobson; Joel Linden; Christa E Müller
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

4.  Functionally biased modulation of A(3) adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers.

Authors:  Zhan-Guo Gao; Dennis Verzijl; Annelien Zweemer; Kai Ye; Anikó Göblyös; Adriaan P Ijzerman; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2011-06-21       Impact factor: 5.858

5.  A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid.

Authors:  C Nordstedt; B B Fredholm
Journal:  Anal Biochem       Date:  1990-09       Impact factor: 3.365

6.  Increased neutrophil adenosine a3 receptor expression is associated with hemorrhagic shock and injury severity in trauma patients.

Authors:  Eileen M Bulger; Cindy M Tower; Keir J Warner; Tara Garland; Joseph Cuschieri; Sandro Rizoli; Shawn Rhind; Wolfgang G Junger
Journal:  Shock       Date:  2011-11       Impact factor: 3.454

7.  Structure-activity relationships of truncated D- and l-4'-thioadenosine derivatives as species-independent A3 adenosine receptor antagonists.

Authors:  Lak Shin Jeong; Shantanu Pal; Seung Ah Choe; Won Jun Choi; Kenneth A Jacobson; Zhan-Guo Gao; Athena M Klutz; Xiyan Hou; Hea Ok Kim; Hyuk Woo Lee; Sang Kook Lee; Dilip K Tosh; Hyung Ryong Moon
Journal:  J Med Chem       Date:  2008-09-24       Impact factor: 7.446

8.  Selective A(3) adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system.

Authors:  Artem Melman; Ben Wang; Bhalchandra V Joshi; Zhan-Guo Gao; Sonia de Castro; Cara L Heller; Soo-Kyung Kim; Lak Shin Jeong; Kenneth A Jacobson
Journal:  Bioorg Med Chem       Date:  2008-08-07       Impact factor: 3.641

9.  Synthesis of ethyl (1S,2R,3S,4S,5S)-2,3-O-(isopropylidene)-4-hydroxy-bicyclo[3.1.0]hexane-carboxylate from L-ribose: a versatile chiral synthon for preparation of adenosine and P2 receptor ligands.

Authors:  Bhalchandra V Joshi; Artem Melman; Richard L Mackman; Kenneth A Jacobson
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2008-03       Impact factor: 1.381

10.  Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A(3) adenosine subtype.

Authors:  Stefania Gessi; Stefania Merighi; Katia Varani; Elena Cattabriga; Annalisa Benini; Prisco Mirandola; Edward Leung; Stephen Mac Lennan; Carlo Feo; Stefania Baraldi; Pier Andrea Borea
Journal:  J Cell Physiol       Date:  2007-06       Impact factor: 6.384

View more
  15 in total

1.  Methanocarba ring as a ribose modification in ligands of G protein-coupled purine and pyrimidine receptors: synthetic approaches.

Authors:  Dilip K Tosh; Kenneth A Jacobson
Journal:  Medchemcomm       Date:  2013-12-17       Impact factor: 3.597

2.  Evidence for the Interaction of A3 Adenosine Receptor Agonists at the Drug-Binding Site(s) of Human P-glycoprotein (ABCB1).

Authors:  Biebele Abel; Dilip K Tosh; Stewart R Durell; Megumi Murakami; Shahrooz Vahedi; Kenneth A Jacobson; Suresh V Ambudkar
Journal:  Mol Pharmacol       Date:  2019-05-24       Impact factor: 4.436

3.  Truncated (N)-Methanocarba Nucleosides as Partial Agonists at Mouse and Human A3 Adenosine Receptors: Affinity Enhancement by N6-(2-Phenylethyl) Substitution.

Authors:  Dilip K Tosh; Veronica Salmaso; Harsha Rao; Amelia Bitant; Courtney L Fisher; David I Lieberman; Helmut Vorbrüggen; Marc L Reitman; Oksana Gavrilova; Zhan-Guo Gao; John A Auchampach; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2020-04-09       Impact factor: 7.446

4.  Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug Design.

Authors:  Antonella Ciancetta; Kenneth A Jacobson
Journal:  Methods Mol Biol       Date:  2018

Review 5.  A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy.

Authors:  Kenneth A Jacobson; Stefania Merighi; Katia Varani; Pier Andrea Borea; Stefania Baraldi; Mojgan Aghazadeh Tabrizi; Romeo Romagnoli; Pier Giovanni Baraldi; Antonella Ciancetta; Dilip K Tosh; Zhan-Guo Gao; Stefania Gessi
Journal:  Med Res Rev       Date:  2017-07-06       Impact factor: 12.944

6.  Synthesis and evaluation of N⁶-substituted apioadenosines as potential adenosine A₃ receptor modulators.

Authors:  Kiran S Toti; Steven M Moss; Silvia Paoletta; Zhan-Guo Gao; Kenneth A Jacobson; Serge Van Calenbergh
Journal:  Bioorg Med Chem       Date:  2014-05-23       Impact factor: 3.641

7.  Structure-Activity Analysis of Biased Agonism at the Human Adenosine A3 Receptor.

Authors:  Jo-Anne Baltos; Silvia Paoletta; Anh T N Nguyen; Karen J Gregory; Dilip K Tosh; Arthur Christopoulos; Kenneth A Jacobson; Lauren T May
Journal:  Mol Pharmacol       Date:  2016-05-02       Impact factor: 4.436

8.  Structural sweet spot for A1 adenosine receptor activation by truncated (N)-methanocarba nucleosides: receptor docking and potent anticonvulsant activity.

Authors:  Dilip K Tosh; Silvia Paoletta; Francesca Deflorian; Khai Phan; Steven M Moss; Zhan-Guo Gao; Xiaohui Jiang; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2012-09-10       Impact factor: 7.446

9.  Rigid Adenine Nucleoside Derivatives as Novel Modulators of the Human Sodium Symporters for Dopamine and Norepinephrine.

Authors:  Aaron Janowsky; Dilip K Tosh; Amy J Eshleman; Kenneth A Jacobson
Journal:  J Pharmacol Exp Ther       Date:  2016-01-26       Impact factor: 4.030

10.  Rational design of sulfonated A3 adenosine receptor-selective nucleosides as pharmacological tools to study chronic neuropathic pain.

Authors:  Silvia Paoletta; Dilip K Tosh; Amanda Finley; Elizabeth T Gizewski; Steven M Moss; Zhan-Guo Gao; John A Auchampach; Daniela Salvemini; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2013-07-03       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.